Patents Examined by Terry A. McKelvey
  • Patent number: 11911417
    Abstract: A nerve growth promoter and an antioxidant containing a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease. A would treatment agent containing an ethyl acetate extract of a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: February 27, 2024
    Assignee: LAIMU CORPORATION
    Inventors: Sachio Wakayama, Akihiro Tai
  • Patent number: 11903990
    Abstract: A method of diminishing the appearance of or effecting the removal or disappearance of seborrheic keratoses by the application of compositions containing a) one or more, preferably a combination of, dietary antioxidants and/or antioxidant sources, b) one or more hydrating agents and c) one or more keratolytic agents.
    Type: Grant
    Filed: January 15, 2022
    Date of Patent: February 20, 2024
    Inventor: William Van Dover Stoecker
  • Patent number: 11903922
    Abstract: Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.
    Type: Grant
    Filed: July 14, 2020
    Date of Patent: February 20, 2024
    Assignee: Amazentis SA
    Inventors: Christopher Rinsch, William Blanco-Bose, Bernard Schneider, Charles Thomas, Carmen Sandi, Johan Auwerx, Penelope Andreux, Richardus Houtkooper, Eija Pirinen, Laurent Mouchiroud, David Genoux
  • Patent number: 11872260
    Abstract: This disclosure is directed to essential oils, and methods of their use in treating skin conditions. The skin conditions include those involving HRASQ61L mutant keratinocyte activity, wherein the essential oil inhibits said activity to treat and/or prevent skin cancer. Particularly, the present invention denotes to and composition for inhibiting and prevent skin carcinogenesis or BRAF inhibitor, a type of anti-cancer drug induced cutaneous side effect.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: January 16, 2024
    Assignee: ACADEMIA SINICA
    Inventors: Lie-Fen Shyur, Chih-Ting Chang, Yuhsin Chen
  • Patent number: 11865106
    Abstract: The invention provides novel pharmaceutical compositions of berberine or a derivative or analog of berberine, or a salt thereof, in combination with one or more omega-3 fatty acids or esters thereof, and methods of their use in treating inflammatory bowel disease.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: January 9, 2024
    Assignee: SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD.
    Inventor: Liping Liu
  • Patent number: 11865121
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: January 9, 2024
    Assignee: Nutrition21, LLC
    Inventor: James R. Komorowski
  • Patent number: 11857578
    Abstract: The invention relates to a new bacterial extract that can be used for protecting and/or treating sensitive skin and/or reactive, intolerant skin, particularly by means of targeted action on neurogenic inflammation of the skin. The invention also relates to cosmetic or dermatological compositions comprising such a bacterial extract as an active ingredient.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: January 2, 2024
    Assignee: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Nathalie Castex-Rizzi, Bertrand Chol, Fabrice Lestienne
  • Patent number: 11857553
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: January 2, 2024
    Assignee: Nutrition21, LLC
    Inventor: James R. Komorowski
  • Patent number: 11857586
    Abstract: The present invention relates to a composition for prevention or treatment of gynecological diseases containing an extract of Sarcodon imbricatus as an active ingredient. Specifically, the extract of Sarcodon imbricatus of the present invention can be effectively used, with only one dose, for prevention or treatment of gynecological diseases by treating dysmenorrhea, reducing a menstrual period, an amount of menstruation, menstrual irregularity, and extravasated blood, and clearing the color of menstruation.
    Type: Grant
    Filed: October 11, 2022
    Date of Patent: January 2, 2024
    Inventor: Hye Jin Woo
  • Patent number: 11833183
    Abstract: A method for improving body shape and improving skin condition using a noni fruit ferment is provided, and the method includes: administrating a composition to a subject in need thereof. The composition includes an effective amount of noni fruit ferment. The noni fruit ferment is prepared by (a) mixing glucose and noni fruit with water for extraction, to obtain a noni fruit broth, and (b) fermenting the noni fruit broth with a plurality of bacteria strains. The bacteria strains include yeast, lactic acid bacteria, and acetic acid bacteria. In step (b), the noni fruit broth and the bacteria strains are irradiated with a red light source with a wavelength of 620 nm to 750 nm. In addition, the noni fruit ferment also has at least one of the following functions: removing free radicals, improving defecation status, and improving gastrointestinal motility.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: December 5, 2023
    Assignee: TCI CO., LTD.
    Inventors: Yung-Hsiang Lin, Pei-Yi Wu
  • Patent number: 11806376
    Abstract: A pharmaceutical composition for treating oral ulcer, a preparation method and an application thereof are provided, which belong to the technical field of pharmaceutical compositions. The pharmaceutical composition includes the following raw materials: 20-50 parts of Sanhuang mixture, 15-20 parts of lotus root powder, 30-50 parts of Galla chinensis, 10-20 parts of Lonicera japonica Thunb., 10-20 parts of vanilla bean, 10-20 parts of propolis, 5-8 parts of oak bark, 5-10 parts of tea, 3-5 parts of Asarum, 1-2 parts of Atractylodes macrocephala and 5-30 parts of chlorhexidine acetate. The pharmaceutical composition for treating oral ulcer has the efficacies of clearing away heat, detoxifying removing blood stasis and reducing swelling, promoting granulation and relieving pain, inhibiting bacteria and killing bacteria, and has the advantages of quick response, easy finding of raw materials and low cost, and has a good therapeutic effect for treating oral ulcer clinically.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: November 7, 2023
    Assignee: SICHUAN TIANFU FINE CHEMICAL CO., LTD.
    Inventors: Chongfu Wang, Kui Wang, Yu Gao
  • Patent number: 11801278
    Abstract: Provided herein is a method of obtaining an extract from a plant biomass as well as an extract obtained from the method. Also provided is a pharmaceutical product, ODF, nutraceutical product, and/or edible product, that includes the extract and one or more excipients. Also provided is a method that includes orally administering the extract (or pharmaceutical product, ODF, nutraceutical product, and/or edible product, that includes the extract).
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: October 31, 2023
    Inventors: Robert Davidson, Vered Gigi, Jose Bernardo
  • Patent number: 11801210
    Abstract: The present invention relates to novel cosmetic and therapeutic uses of one or more compounds of the general formula (1) as described herein. Furthermore, the present invention relates to compositions (products or, respectively, formulations), in particular for topical administration, preferably cosmetic or pharmaceutical compositions, comprising or consisting of compound(s) of formula (1) and one or more cosmetically and/or pharmaceutically acceptable carriers. The present invention also relates to novel uses of such compositions according to the invention.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: October 31, 2023
    Assignee: SYMRISE AG
    Inventors: Dominik Stuhlmann, Ann-Christin Weseloh, Nicole Titze, Sabine Lange, Sebastian Bruncke, Benoît Join, Gabriele Vielhaber, Marielle Le Maire, Karima Benaissi
  • Patent number: 11801220
    Abstract: The present invention relates to the use of pomegranate oil and fractions thereof for preventing and treating neurodegenerative diseases. Particularly, the present invention relates to emulsions of the pomegranate oil or fractions thereof for the prevention and treatment of brain diseases, including Creutzfeldt-Jacob disease (CJD) and multiple sclerosis (MS).
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: October 31, 2023
    Assignees: Hadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Ruth Gabizon, Haim Ovadia, Oded Abramsky, Shlomo Magdassi, Liraz Larush
  • Patent number: 11793846
    Abstract: Disclosed is a method for preparing bitter Ganoderma lucidum spore powder, and relates to the field of drugs or health care products. The method includes: removing visible impurities from Ganoderma lucidum spores, conducting ice bath and heating extraction, filtering through a microfiltration membrane, sterilizing by drying, and conducting sporoderm disruption to obtain the bitter Ganoderma lucidum spore powder. The preparation method effectively improves the content of the bitter substances in the Ganoderma lucidum spore powder by removing shriveled spores through multiple times of impurity removal and filtration in combination with the manner of conducting sporoderm disruption after extraction. Taking the total Ganoderma lucidum triterpenoids in the Ganoderma lucidum spores as a representative of the bitter substances, the content of the total Ganoderma lucidum triterpenoids can reach 5-8%. Meanwhile, the preparation method can also make the content of Ganoderma lucidum polysaccharides reaching 6-10%.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: October 24, 2023
    Assignees: Zhejiang Shouxiangu Pharmaceutical Company, Ltd, Jinhua Shouxiangu Pharmaceutical Co. Ltd
    Inventors: Zhenhao Li, Jing Xu, Ying Wang, Yuejiao Shi, Mingyan Li
  • Patent number: 11793851
    Abstract: The present invention relates to a method for treating a side effect caused by bacillus Calmette-Guérin (BCG) perfusion therapy for bladder cancer. The method includes: administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture comprising Gentiana scabra, Scutellariae Radix, Gardeniae Fructus, Angelicae Sinensis Radix, Rehmanniae radix, Akebiae Caulis, Bupleurum chinense, Plantaginis Semen, Atractylodes lancea, Rhizoma alismatis, and Glycyrrhiza uralensis.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: October 24, 2023
    Inventor: Chen-Yu Lee
  • Patent number: 11779620
    Abstract: Described herein are combined fungal compositions for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that causes an inflammatory response. In one aspect the composition comprises an aqueous or solid fraction of Trametes versicolor and Fomitopsis officinalis mycelium, fermented substrates thereof, or combinations thereof.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: October 10, 2023
    Assignee: TURTLE BEAR HOLDINGS, LLC
    Inventor: Paul E. Stamets
  • Patent number: 11771638
    Abstract: A non-aqueous composition is disclosed that includes ascorbic acid, a silicone oil, at least 15% by weight of an essential oil, propylene glycol, and glycerin, wherein at least 50% of the initial amount of ascorbic acid in the non-aqueous composition remains stable when the composition is stored for at least 1 month at room temperature.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: October 3, 2023
    Assignee: MARY KAY INC.
    Inventor: Isaac Thomas
  • Patent number: 11766397
    Abstract: The present invention provides bioactive compositions comprising Ficus serum fraction derived from Ficus cell juice of fresh Ficus leaves and a process of preparing the Ficus serum fraction. The compositions have biological activity capable of reducing skin hyperpigmentation.
    Type: Grant
    Filed: December 7, 2019
    Date of Patent: September 26, 2023
    Assignee: ISP INVESTMENTS LLC
    Inventor: Michael Koganov
  • Patent number: 11759493
    Abstract: A composition containing a synergistic association of lactitol, lactulose and Rhamnus frangula extract for the treatment of constipation is described.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: September 19, 2023
    Assignee: NEILOS S.R.L.
    Inventor: Umberto Di Maio